Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 213-086-1 | N-(hydroxymethyl)methacrylamide | 923-02-4 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Wng |
Note D
|
State/Form
|
7 |  |
View details | |||
| Skin Sens. 1B | H317 | H317 | |||||||||
| STOT SE 2 | H371 (Nervous system) (oral) | H371 (AFFECTED ORGANS...) | |||||||||
| STOT RE 2 | H373 (Nervous system) (oral) | H373 (AFFECTED ORGANS...) | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS07 GHS08 Wng |
State/Form
|
87 | View details | |||||
| Skin Sens. 1B | H317 | H317 | |||||||||
| STOT SE 2 | H371 (other:Nervous s...) | H371 | |||||||||
| STOT SE 2 | H371 (Nervous system) | H371 | |||||||||
| STOT RE 2 | H373 (other:Nervous s...) | H373 | |||||||||
| STOT RE 2 | H373 (Nervous system) | H373 | |||||||||
| Acute Tox. 3 | H301 | H301 |
GHS06 Dgr |
38 | View details | ||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Wng |
31 | View details | ||||||
| Skin Sens. 1B | H317 | H317 | |||||||||
| STOT SE 2 | H371 (other:Nervous s...) (oral) | H371 (May cause damag...) | |||||||||
| STOT RE 2 | H373 (other:Nervous s...) (oral) | H373 (May cause damag...) | |||||||||
| Not Classified | 16 | ||||||||||
| H302 |
GHS07 Wng |
6 | View details | ||||||||
| Acute Tox. 4 | H312 | H312 | |||||||||
| Acute Tox. 4 | H332 | ||||||||||
Number of Aggregated Notifications: 6